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Introduction
Neuroepidemiology is a peer-reviewed international journal that publishes manuscripts on all aspects of epidemiology of neurological disorders, including clinical trials and systematic reviews. Its primary focus is on chronic and acute neurological disorders of major importance to clinical medicine, public health, and health care delivery. The journal encourages the use of epidemiology in a multidisciplinary approach to the understanding of neurological disease distribution and determinants of frequency in human populations. The journal also welcomes manuscripts dealing with methodological issues in neuroepidemiological studies. Fast-track evaluation and publication will be secured by online submission, evaluation, and prompt decision, as well as by fast on-line publication of accepted manuscripts, followed by their hard-copy publication.
Submission
Only original papers written in English are considered and should be submitted online:
www.karger.com/ned
Should you experience problems with your submission, please contact:
Svetlana.feigin@auckland.ac.nz
Editorial Office 'Neuroepidemiology' National Institute for Stroke and Applied Neurosciences Auckland University of Technology AA254, 90 Akoranga Drive, Northcote 0627 Private Bag 92006, Auckland 1142 New Zealand Fax +64 9 921 9620 All manuscripts must be accompanied by a short cover letter to the Editor signed by all authors stating that they agree to the publication of the manuscript. The cover letter should be uploaded during the online submission process.
Names, postal and e-mail adresses of 5 experts in the appropriate area of research should accompany each manuscript. Referees suggested should not be from the same institution or be research collaborators of the author(s).
Conditions
All manuscripts are subject to editorial review. Manuscripts are received with the explicit understanding that they have not been previously published elsewhere and are not under simultaneous consideration by any other publication. Submission of an article for publication implies transfer of copyright from the author to the publisher upon acceptance. Accepted papers become the permanent property of Neuroepidemiology and may not be reproduced by any means, in whole or in part, without the written consent of the publisher. It is the author's responsibility to obtain permission to reproduce illustrations, tables, etc. from other publications.
Conflicts of Interest
Authors are required to disclose any sponsorship or funding arrangements relating to their research and all authors should disclose any possible conflicts of interest. Conflict of interest statements will be published at the end of the article.
Ethics
Published research must comply with the guidelines for human studies and animal welfare regulations. Authors should state that subjects have given their informed consent and that the study protocol has been approved by the institute's committee on human research. Further, they should also state that animal experiments conform to institutional standards.
Categories of Manuscripts (Word limits include tables, illustrations and references)
Original Papers are full-length research papers which will be considered for the journal. Articles cover topics relevant to neuroepidemiological studies (max. 2,500 words).
Reviews are comprehensive, state-of-the-art papers (systematic reviews or meta-analyses) of important epidemiological or clinical problems relevant to neurological disorders. Reviews may be invited by the Editor or they may be unsolicited views (max. 5,000 words), although in the latter, we ask the author to send the Editor a short outline first (300-400 words) to ensure that a review on a similar subject has not already been commissioned. Manuscripts will be assessed in-house and those judged suitable will be peer reviewed before an editorial decision is made. An Abstract is required and should be divided into Background, Summary and Key Messages.
Editorials are usually invited by the Editor (max. 1,000 words). Please send suggestions to the Editor.
Methods in Neuroepidemiology papers dealing with methodological issues in current neuroepidemiologic studies (e.g. recruitment, exclusion and inclusion criteria, methodological evaluation, novel approaches to clinical trials, statistical analyses and follow-up problems and solutions), particularly with regard to ongoing large population-based studies, controlled clinical trials, cohort and case-control studies are welcome (max. 5,000 words).
Letters to the Editor and Opinions. Manuscripts of max. 500 words, 1 figure or table and max. 10 references are considered for publication provided they describe a novel observation or add pertinent new information into the epidemiology or health care of a neurological disease.
Reporting Guidelines
According to the type of the article, we recommend authors to adhere to the following reporting guidelines:
Observational non-experimental studies (cohort, casecontrol, and cross-sectional studies): The STROBE (STrengthening the Reporting of OBservational studies in Epidemiology) statement (www.strobe-statement.org).
Reporting randomized controlled trials: The CON-SORT (Consolidated Standards of Reporting Trials) statement (www.consort-statement.org). Meta-analysis of randomized controlled trials: The Cochrane Collaboration guidelines (www.cochrane.org/ resources/handbook). Meta-analysis of observational studies in epidemiology: The MOOSE (Meta-analysis of Observational Studies in Epidemiology) statement (JAMA 2000; 283:2008 -2012 .
All systematic reviews must describe search strategy, data sources (databases, journals, books, etc) and criteria used to include or exclude studies.
Arrangement
All manuscripts should be arranged in the following order:
(1) Title (2) Key words and abstract (3) Text (4) Acknowledgments and funding (5) References (6) Tables (7) Figure legends All manuscripts must be typed in double-space, including references, figure legends, and tables, with 1-inch (2.54 cm) margins on all sides. Number every page, beginning with the abstract, including tables, figure legends, and figures, and cite each figure and table in the text numerically. All references must be cited in the text consecutively and be listed in the References.
Title page: The first page of each paper should indicate the title, the authors' names, the institute where the work was conducted, and a short title for use as running head. The number of figures and tables should also be indicated.
Full address:
The exact postal address of the corresponding author complete with postal code must be given at the bottom of the title page. Please also supply phone and fax numbers, as well as e-mail address.
Key words: Please supply 3-10 key words in English that reflect the content of the paper at the bottom of the title page.
Abstract: The Abstract is essential. It should be printed on a separate page (up to 200 words; any abbreviations must be explained) and structured as follows:
Background: Rationale and purpose of the study. Methods: How the study was performed (samples and/or population, procedures, analytical methods 
Self-Archiving/Green Open Access
Karger permits authors to archive their pre-prints (i.e. pre-peer review) or post-prints (i.e. accepted manuscript after peer review but before production) on their personal or their institution's internal website. In addition, authors may post their accepted manuscripts in public Open Access repositories and scientific networks (e.g. ResearchGate or Mendeley) no earlier than 12 months following publication of the final version of their article. For all self-archiving, the posted manuscripts must:
• Be used for noncommercial purposes only It is the author's responsibility to fulfill these requirements.
For papers published online first with a DOI number only, full citation details must be added as soon as the paper is published in its final version. This is important to ensure that citations can be credited to the article. Manuscripts to be archived in PubMed Central due to funding requirements will be submitted by Karger on the author's behalf [see Funding Organizations (NIH etc.)].
For self-archiving Author's Choice TM (Gold Open Access) articles, see Author's Choice TM .
Author's Choice TM
Karger's Author's Choice TM service broadens the reach of your article and gives all users worldwide free and full access for reading, downloading and printing at www.karger.com. The option is available for a onetime fee of CHF 3,000.00, which is a permissible cost in grant allocation. More information can be found at www.karger.com/authors_choice. The final, published version of the article may be posted at any time and in any repository or on other websites, in accordance with the relevant Creative Commons license. Reposted Open Access articles must: It is the author's responsibility to fulfill these requirements.
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Funding Organizations (NIH etc.)
The U.S. National Institutes of Health (NIH) Public Access Policy mandates that accepted, peer-reviewed manuscripts are archived in its digital database, PubMed Central (PMC), within 12 months of the official publication date. As a service to authors, Karger submits NIH-funded articles to PMC on behalf of the authors immediately upon publication. The NIH assigns a PMCID within approximately 1 month and the manuscript will appear in PMC after a 12-month embargo. For authors making their paper Open Access through Author's Choice TM , the embargo will be overridden, thereby accelerating the accessibility of the article. Karger also complies with other funders' requirements (including Wellcome Trust and RCUK) for submission to PMC. Authors should include information on their grants in the Acknowledgements section of their papers.
Medical Statistics has never been easier!
The easiest way to order: w w w.karger.com/medical_ statistics The fifth revised edition of this highly successful book presents the most extensive enhancement since Using and Understanding Medical Statistics was first published 30 years ago. Without question, the single greatest change has been the inclusion of source code, together with selected output, for the awardwinning, open-source, statistical package known as R. This innovation has enabled the authors to deemphasize formulae and calculations, and let software do all of the 'heavy lifting' . This edition also introduces readers to several graphical statistical tools, such as Q-Q plots to check normality, residual plots for multiple regression models, funnel plots to detect publication bias in a metaanalysis and Bland-Altman plots for assessing agreement in clinical measurements. New examples that better serve the expository goals have been added to a half-dozen chapters. In addition, there are new sections describing exact confidence bands for the Kaplan-Meier estimator, as well as negative binomial and zero-inflated Poisson regression models for overdispersed count data. The end result is not only an excellent introduction to medical statistics, but also an invaluable reference for every discerning reader of medical research literature. Editor-in-Chief V. Chan-Palay, Singapore
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